These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2315953)

  • 21. Improvement of in vitro two-stage transformation assay and determination of the promotional effect of cadmium.
    Fang MZ; Kim DY; Lee HW; Cho MH
    Toxicol In Vitro; 2001 Jun; 15(3):225-31. PubMed ID: 11377095
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Isolation of methylcholanthrene-"initiated" C3H/10T1/2 cells by inhibiting neoplastic progression with retinyl acetate.
    Mordan LJ; Bergin LM; Budnick JE; Meegan RR; Bertram JS
    Carcinogenesis; 1982; 3(3):279-85. PubMed ID: 7083469
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reversal of the promotional effect of 12-O-tetradecanoylphorbol-13-acetate on morphological transformation of hamster embryo cells by glucocorticoids.
    Rivedal E
    Cancer Lett; 1982 Feb; 15(2):105-13. PubMed ID: 6284350
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dysregulation of pathways involved in the processing of cancer and microenvironment information in MCA + TPA transformed C3H/10T1/2 cells.
    Priya S; Nigam A; Bajpai P; Kumar S
    In Vitro Cell Dev Biol Anim; 2013 Apr; 49(4):295-305. PubMed ID: 23519560
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of initiating as well as promoting activity of chemicals by a novel cell transformation assay using v-Ha-ras-transfected BALB/c 3T3 cells (Bhas 42 cells).
    Asada S; Sasaki K; Tanaka N; Takeda K; Hayashi M; Umeda M
    Mutat Res; 2005 Dec; 588(1):7-21. PubMed ID: 16260176
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nalidixic acid and oxolinic acid reversibly suppress 3-methylcholanthrene-induced cell transformation of BALB/3T3 mouse cells.
    Kaneko M; Horikoshi J
    Int J Cancer; 1988 Dec; 42(6):913-6. PubMed ID: 3192335
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-transforming nature of ascorbic acid and its derivatives examined by two-stage cell transformation using BALB/c 3T3 cells.
    Tsuchiya T; Kato-Masatsuji E; Tsuzuki T; Umeda M
    Cancer Lett; 2000 Nov; 160(1):51-8. PubMed ID: 11098084
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship between exposure to TPA and appearance of transformed cells in MNNG-initiated transformation of BALB/c 3T3 cells.
    Tsuchiya T; Umeda M
    Int J Cancer; 1997 Oct; 73(2):271-6. PubMed ID: 9335454
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Investigation of the mechanism for enhancement of radiation transformation in vitro by 12-O-tetradecanoylphorbol-13-acetate.
    Kennedy AR; Little JB
    Carcinogenesis; 1980; 1(12):1039-47. PubMed ID: 11272108
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Deficiency of tyrosine phosphorylation in a Balb/c 3T3 cell variant hypersensitive to phorbol ester-induced cell transformation.
    Enomoto T; Asano Y
    Carcinogenesis; 1994 Jun; 15(6):1093-7. PubMed ID: 8020139
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Inhibitory effect of a third generation retinoid R8923 and all-trans retinoic acid on two-stage chemical carcinogenesis of BALB/3T3-A31 cells in vitro].
    Guo CY; Han R
    Zhonghua Zhong Liu Za Zhi; 1994 May; 16(3):163-6. PubMed ID: 7956690
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhancement of oncogenesis in C3H/10T1/2 mouse embryo cell cultures by saccharin.
    Mondal S; Brankow DW; Heidelberger C
    Science; 1978 Sep; 201(4361):1141-2. PubMed ID: 684434
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Initiating activity of 1,1,2,2-tetrachloroethane in two-stage BALB/c 3T3 cell transformation.
    Colacci A; Perocco P; Bartoli S; Da Via C; Silingardi P; Vaccari M; Grilli S
    Cancer Lett; 1992 Jun; 64(2):145-53. PubMed ID: 1611598
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Initiating activity of 3-tert-butyl-4-hydroxyanisole (3-BHA) and its metabolites in two-stage transformation of BALB/3T3 cells.
    Sakai A; Miyata N; Takahashi A
    Carcinogenesis; 1990 Nov; 11(11):1985-8. PubMed ID: 2225330
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Possible implication of arachidonic acid metabolism in the decrease of chemiluminescence production after exposure of murine peritoneal macrophages to diethylnitrosamine and tumour promoter, 12-O-tetradecanoylphorbol-13-acetate.
    Forgue MF; Pipy B; Beraud M; Pinelli E; Cambon C; Didier A; Souqual MC; Vandaele J
    Carcinogenesis; 1991 Mar; 12(3):449-57. PubMed ID: 1901251
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Two-stage malignant transformation in hamster embryo cells.
    Poiley JA; Raineri R; Pienta RJ
    Br J Cancer; 1979 Jan; 39(1):8-14. PubMed ID: 758930
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Establishment of a highly reproducible transformation assay of a ras-transfected BALB 3T3 clone by treatment with promoters.
    Sasaki K; Mizusawa H; Ishidate M; Tanaka N
    Basic Life Sci; 1990; 52():411-6. PubMed ID: 2183779
    [No Abstract]   [Full Text] [Related]  

  • 38. Prostaglandin modulation of phorbol ester skin tumor promotion.
    Fischer SM; Gleason GL; Hardin LG; Bohrman JS; Slaga TJ
    Carcinogenesis; 1980 Mar; 1(3):245-8. PubMed ID: 22283005
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discrete roles of cytokines, TNF-alpha, IL-1, IL-6 in tumor promotion and cell transformation.
    Suganuma M; Okabe S; Kurusu M; Iida N; Ohshima S; Saeki Y; Kishimoto T; Fujiki H
    Int J Oncol; 2002 Jan; 20(1):131-6. PubMed ID: 11743653
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhancement by 1 alpha,25-dihydroxyvitamin D3 of chemically induced transformation of BALB 3T3 cells without induction of ornithine decarboxylase or activation of protein kinase C1.
    Sasaki K; Chida K; Hashiba H; Kamata N; Abe E; Suda T; Kuroki T
    Cancer Res; 1986 Feb; 46(2):604-10. PubMed ID: 3000580
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.